Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna and sponsored by the University of Oxford, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer. 👏
www.cancer.ox.ac.uk/news/first-t...
Some great discussion & collaboration at today's Oxford Pancreatic Cancer Research Networking Day! 👏
Featuring a talk on Patient and Public Involvement (PPI) in research from our wonderful PPI Team!
More on our website 👇
www.cancer.ox.ac.uk/support/PPI-...
#PancreaticCancer #CancerResearch
New paper from lab: many congratulations to Rebecca, Alia and Lucy who led this work. And thanks to all collaborators and funders. @paediatrics.ox.ac.uk @imm.ox.ac.uk @oxfordcancer.bsky.social ashpublications.org/blood/articl...
We're delighted to share the appointment of Prof Adam Mead as Director of Oxford Cancer, joining Profs Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research community. 👏
@ouhospitals.bsky.social @medsci.ox.ac.uk @imm.ox.ac.uk
www.cancer.ox.ac.uk/news/profess...
Key Points. LIN28B, a fetal specific oncogene, is necessary for fetal B lymphopoiesis and KMT2A::AFF1 initiation of infant B ALLLIN28B stabilizes key fetal
Oxford Cancer is delighted to announce the appointment of Professor Adam Mead as Director, joining Professors Mark Middleton and Tim Elliott in leading Oxford’s interdisciplinary cancer research commu...
www.cancer.ox.ac.uk
Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has...
A big thank you to everyone who joined us for yesterday's Oxford Pancreatic Cancer Research Networking Day! 👏
The day showcased the breadth of #PancreaticCancer research taking place across our community and highlighted the importance of collaboration in driving progress for patients.
And we're off! 🎉
@sarahblagden.bsky.social kicks off today's #PPIE event, exploring the potential of treatments to prevent cancer with our fantastic public and patient contributors. ✨
Oxford Cancer
A change of scene for today! @oxfordcancer.bsky.social has taken over the cinema for a day to talk about preventing cancer with vaccines with our brilliant public and patient contributors.
Looking forward to an interesting day of discussions!
#PPIE
Oxford Cancer
The Fellows of the AACR Academy Cancer Research Impact Grants are one-year, $75,000 awards that support early-career investigators nearing completion of postdoctoral or clinical research training. Apply by June 30. Learn more:
buff.ly/GeLhnOj
#AACRGrants
Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more:
buff.ly/98T3KHj
#SABCS26
Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes.
buff.ly/pSzoa0m
#AACRpan26
